magnolol has been researched along with Sepsis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miao, B; Wang, BE; Wang, H; Yang, T; Zhang, S; Zhou, D | 1 |
| Ren, AM; Sun, LN; Wang, H; Yang, TC; Zhang, SW | 1 |
| Lee, CH; Shih, HC; Wei, YH | 1 |
| Chan, WL; Chin, JH; Hong, CY; Kong, CW; Tsai, K | 1 |
4 other study(ies) available for magnolol and Sepsis
| Article | Year |
|---|---|
Magnolol pretreatment prevents sepsis-induced intestinal dysmotility by maintaining functional interstitial cells of Cajal.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Cell Count; Gastrointestinal Motility; Gerbillinae; Interstitial Cells of Cajal; Lignans; Lipopolysaccharides; Male; Malondialdehyde; Mice; Muscle Contraction; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Proto-Oncogene Proteins c-kit; RNA, Messenger; Sepsis; Stem Cell Factor; Superoxide Dismutase; Up-Regulation | 2013 |
Magnolol attenuates sepsis-induced gastrointestinal dysmotility in rats by modulating inflammatory mediators.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Chemokine CCL2; Disease Models, Animal; Gastrointestinal Diseases; Gastrointestinal Motility; Ileum; Inflammation Mediators; Interleukin-10; Lignans; Lipopolysaccharides; Male; Malondialdehyde; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; RNA, Messenger; Sepsis; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2008 |
Magnolol alters cytokine response after hemorrhagic shock and increases survival in subsequent intraabdominal sepsis in rats.
Topics: Animals; Biphenyl Compounds; Cytokines; Interleukin-10; Lignans; Lung Injury; Male; Rats; Rats, Sprague-Dawley; Sepsis; Shock, Hemorrhagic; Time Factors; Tumor Necrosis Factor-alpha | 2003 |
Magnolol attenuates peroxidative damage and improves survival of rats with sepsis.
Topics: Animals; Anti-Infective Agents; Biphenyl Compounds; Cecum; Dose-Response Relationship, Drug; Drug Administration Schedule; Drugs, Chinese Herbal; Lignans; Lipid Peroxidation; Liver; Lung; Male; Punctures; Rats; Rats, Sprague-Dawley; Sepsis; Survival Rate | 2000 |